<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000635679"><TermName>ABVD regimen</TermName><TermPronunciation>(… REH-jih-men)</TermPronunciation><TermDefinition><DefinitionText>An abbreviation for a chemotherapy combination used to treat Hodgkin lymphoma. It includes the drugs doxorubicin hydrochloride (Adriamycin), bleomycin sulfate, vinblastine sulfate, and dacarbazine. Also called ABVD.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000722822" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;ABVD regimen&quot;" language="en" id="_3"/><MediaLink ref="CDR0000722821" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen ABVD&quot;" language="es" id="_4"/><SpanishTermName>régimen ABVD</SpanishTermName><SpanishTermDefinition><DefinitionText>Abreviatura del nombre de una quimioterapia combinada que se usa para tratar el linfoma de Hodgkin. Incluye los siguientes medicamentos: clorhidrato de doxorrubicina (Adriamycin), sulfato de bleomicina, sulfato de  vinblastina y dacarbazina. También se llama ABVD.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2009-02-20</DateFirstPublished><DateLastModified>2010-05-05</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000632567">ABVD</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
